Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: Novel concerns
J Hepatol
.
2018 Jun;68(6):1315-1316.
doi: 10.1016/j.jhep.2018.01.039.
Epub 2018 Feb 20.
Authors
Meng Sha
1
,
Seogsong Jeong
1
,
Qiang Xia
2
Affiliations
1
Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China.
2
Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Electronic address:
[email protected]
.
PMID:
29475065
DOI:
10.1016/j.jhep.2018.01.039
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents*
Bile Duct Neoplasms / surgery*
Bile Ducts, Intrahepatic*
Cholangiocarcinoma / surgery*
Hepatectomy
Hepatitis B virus
Humans
Substances
Antiviral Agents